Akshyaya Pradhan
Akshyaya Pradhan is an expert in Cardiology at King George's Medical University (India). As of October 2026, ScienceLeadR ranks Akshyaya Pradhan in the top 1% of experts in India for Myocardial Ischemia. Akshyaya Pradhan has authored 236 publications, the most recent in 2026. SLR score: 691 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Pulmonology - General Medicine - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2013 - 2026
Number : 236
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Efficacy and Safety of Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. PMID 42930051 — idiopathic pulmonary fibrosis, mortality, lung, hypertension, pulmonary, safety, fibrosis, pulmonary fibrosis, records, lung diseases, vital capacity | Adv Respir Med | 2026 | 0 |
| Early efficacy of oral lipid lowering therapy in achieving LDL-C targets following acute coronary syndrome: A real-world observational study. PMID 42898193 — diabetes mellitus, cholesterol, ldl, acute coronary syndrome, cholesterol, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors, diabetes mellitus, type 2 | Am Heart J Plus | 2026 | 0 |
| Beyond Traditional Lipid Lowering: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition. PMID 42866070 — ezetimibe, lipoproteins, cholesterol esters, risk management, cholesterol, cholesterol ester transfer proteins, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors, lipoprotein(a), esters | Eur Cardiol | 2026 | 0 |
| Overcoming Hyperkalaemia to Optimise Heart Failure Therapy: The Emerging Role of Novel Potassium Binders. PMID 42866084 — heart failure, heart, therapeutics, mineralocorticoid receptor antagonists | Card Fail Rev | 2026 | 0 |
| Estimation of Endothelin Levels in Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension: A Clinical Insight. PMID 42844875 — hypertension, hypertension, pulmonary, endothelins, spirometry, pulmonary disease, chronic obstructive, echocardiography, lung diseases, vital capacity, lung diseases, obstructive, hemodynamics | Ann Afr Med | 2026 | 0 |
LeadR Networks
Main global connection map